Aspirin’s Survival Benefits in Advanced CRC Depend on Patient BMI
Elisa Becze, BA, ELS, Editor
Voice
Description
Regular use of aspirin after an advanced colorectal cancer diagnosis may extend survival by as much as 14 months for patients with a healthy body mass index (BMI) score prediagnosis compared to those with obese BMIs, researchers reported in JAMA Network Open.